| Pfizer AG - Xeljanz 5 mg, Filmtabletten | | 62630 | | 01 | | Xeljanz 5 mg | | Filmtabletten | | L04AF01 | | Tofacitinib | | 12.07.2013 | | |
| | Composition | | tofacitinibum 5 mg ut tofacitinibi citras, cellulosum microcristallinum, lactosum monohydricum 61.307 mg, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum 1.26 mg, macrogolum 3350, triacetinum, pro compresso obducto corresp. natrium max. 0.54 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Tofacitinibum | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Tofacitinibum | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 1.26 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 Tablet(s) | 410.28 | 460.30 | B | SL | No |
|
|
